Odyssey buys BenevolentAI in Europe's top SPAC deal
Investment Into Biosciences Boomed, Could The Bubble Burst?
How AI Is Aiming at the Bad Math of Drug Development
Drug discovery platform Exscientia sets terms for $275 million US IPO
Venture Investors Turn To AI To Find Deal
Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report
Globalization and Democratization of Innovation
390 Startup Failure Post-Mortems
ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie
Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus
ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding
